You are viewing an expired study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

Palo Alto, California

  • Stroke Prevention in Patients With Atrial Fibrillation

Purpose:

The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin.


Criteria:

Inclusion Criteria: - Signed informed consent. - Completion of the study SH-TPA-0002, history of chronic atrial fibrillation (i.e. rapidly beating heart), at least one risk factor for stroke (e.g. high blood pressure, age over 65, previous stroke or similar attack, diabetes or coronary heart disease) Exclusion Criteria: - Conditions associated with increased risk of bleeding, renal impairment, known active liver disease or liver insufficiency


NCT ID:

NCT00206063


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Palo Alto, California
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 30, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.